129 related articles for article (PubMed ID: 21838482)
1. Amyloid turnover after liver transplantation in FAP.
Obayashi K; Ueda M; Jono H; Yamashita T; Yazaki M; Kametani F; Ohya Y; Inomata Y; Ikeda S; Ando Y
Amyloid; 2011 Jun; 18 Suppl 1():187-9. PubMed ID: 21838482
[No Abstract] [Full Text] [Related]
2. Finding of vascular amyloid TTR in inferior nasal concha in a patient with FAP TTRVal30Met.
Munar-Ques M; Martinez-Nadal J; Torres-Rovira JJ; Sole M; Zabay-Becerril JM; Mulet-Ferrer JM
Amyloid; 2008 Dec; 15(4):272-4. PubMed ID: 19065300
[TBL] [Abstract][Full Text] [Related]
3. Familial amyloid polyneuropathy and liver transplantation.
Monteiro E; Freire A; Barroso E
J Hepatol; 2004 Aug; 41(2):188-94. PubMed ID: 15288465
[No Abstract] [Full Text] [Related]
4. [Familial amyloid polyneuropathy: liver transplantation as first-line therapy].
Yamashita T
Brain Nerve; 2014 Jul; 66(7):763-71. PubMed ID: 24998821
[TBL] [Abstract][Full Text] [Related]
5. Clinical picture and outcome of transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients.
Ikeda S
Clin Chem Lab Med; 2002 Dec; 40(12):1257-61. PubMed ID: 12553427
[TBL] [Abstract][Full Text] [Related]
6. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients.
Oguchi K; Takei Y; Ikeda S
Amyloid; 2006 Jun; 13(2):99-107. PubMed ID: 16911964
[TBL] [Abstract][Full Text] [Related]
7. Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
Sakashita N; Ando Y; Haraoka K; Terazaki H; Yamashita T; Nakamura M; Takeya M
Pathol Int; 2006 Jul; 56(7):408-12. PubMed ID: 16792551
[TBL] [Abstract][Full Text] [Related]
8. Combined liver-kidney transplantation in familial amyloidotic polyneuropathy TTR V30M: nephrological assessment.
Lobato L; Beirão I; Seca R; Pessegueiro H; Rocha MJ; Queiroz J; Gomes M; Henriques AC; Teixeira M; Almeida R
Amyloid; 2011 Jun; 18 Suppl 1():190-2. PubMed ID: 21838483
[No Abstract] [Full Text] [Related]
9. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation in transthyretin amyloidoses. When the neurological benefit outweighs the risk.
Mascalchi M; Salvi F
Neurol Sci; 2006 Nov; 27(5):297-8. PubMed ID: 17122935
[No Abstract] [Full Text] [Related]
11. Biochemical characterization of vitreous amyloid formed after liver transplantation.
Liepnieks JJ; Phan AD; Wise RJ; Hrisomalos FN; Benson MD
Amyloid; 2016 Jun; 23(2):136-7. PubMed ID: 27043487
[No Abstract] [Full Text] [Related]
12. Domino liver transplantation: risks and benefits.
Ericzon BG; Larsson M; Wilczek HE
Transplant Proc; 2008 May; 40(4):1130-1. PubMed ID: 18555132
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience.
Barreiros AP; Post F; Hoppe-Lotichius M; Linke RP; Vahl CF; Schäfers HJ; Galle PR; Otto G
Liver Transpl; 2010 Mar; 16(3):314-23. PubMed ID: 20209591
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
Ikeda K; Kano O; Ito H; Kawase Y; Iwamoto K; Sato R; Sekine T; Nagata R; Nakamura Y; Hirayama T; Iwasaki Y
Neurology; 2008 Apr; 70(17):1576; author reply 1576-7. PubMed ID: 18427077
[No Abstract] [Full Text] [Related]
15. Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning?
Lauro A; Diago Usò T; Masetti M; Di Benedetto F; Cautero N; De Ruvo N; Dazzi A; Quintini C; Begliomini B; Siniscalchi A; Ramacciato G; Risaliti A; Miller CM; Pinna AD
Transplant Proc; 2005 Jun; 37(5):2214-20. PubMed ID: 15964382
[TBL] [Abstract][Full Text] [Related]
16. Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients.
Beirão NM; Matos ME; Meneres MJ; Beirão IM; Costa PP; Torres PA
Amyloid; 2012 Sep; 19(3):146-51. PubMed ID: 22856884
[TBL] [Abstract][Full Text] [Related]
17. Effect of recipient-derived cells on the progression of familial amyloidotic polyneuropathy after liver transplantation: a retrospective study.
Ohya Y; Jono H; Nakamura M; Hayashida S; Ueda M; Obayashi K; Misumi S; Asonuma K; Ando Y; Inomata Y
Ann Clin Biochem; 2010 Nov; 47(Pt 6):529-34. PubMed ID: 20930032
[TBL] [Abstract][Full Text] [Related]
18. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
Suhr OB
Amyloid; 2003 Aug; 10 Suppl 1():77-83. PubMed ID: 14640045
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin-related familial amyloidotic polyneuropathy.
Ando Y; Nakamura M; Araki S
Arch Neurol; 2005 Jul; 62(7):1057-62. PubMed ID: 16009758
[TBL] [Abstract][Full Text] [Related]
20. Presence of autoantibody against ATTR Val30 Met after sequential liver transplantation.
Suhr OB; Lundgren E
Transplantation; 2002 Mar; 73(5):674-5. PubMed ID: 11907408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
